Nectar Lifesciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2025
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences Limited held its 30th AGM on September 29, 2025 via video conferencing, chaired by Managing Director Mr. Sanjiv Goyal, and it concluded in about 33 minutes. All 5 directors were present, along with the CEO, CFO, statutory auditors, and secretarial auditors. Both the statutory auditor (M/s. Deepak Jindal & Co.) and secretarial auditor (M/s. P. Chadha & Associates) gave clean, unqualified opinions on the FY 2024-25 financial statements with no adverse remarks. Shareholders voted on 5 resolutions through remote e-voting and an electronic poll at the meeting, covering adoption of FY25 financial statements, re-appointment of Mr. Sanjiv Goyal as director (retiring by rotation), ratification of cost auditor remuneration, appointment of the secretarial auditor, and adoption of a new set of Articles of Association. Voting results are to be shared with the stock exchanges within 2 working days.
This is largely a routine procedural filing, but the clean audit opinion for FY25 is a mildly positive signal. The adoption of new Articles of Association is worth watching as it can change how the company is governed, while the re-appointment of the long-serving MD indicates leadership continuity.